This project has been flagged by a community member as inappropriate due to reason below.*
Slingshot & STAT have partnered to provide you with interviews with experts led by STAT's reporters. This call is on:

Branching into the world of health tech, join STAT Reporters and a cardiologist for a call about the Apple watch HEARTLINE trial run in partnership with Johnson & Johnson

Ticker(s): AAPL, JNJ

Who's the expert?

Name: Dr Jonathan Hsu - MD

Institution: University of California, San Diego

  • Associate Professor Cardiac Electrophysiology, Division of Cardiology at University of California, San Diego (UCSD).
  • Currently manages >500 patients with Atrial Fibrillation.
  • Clinical research investigator with advanced training, and his interests include epidemiology and clinical outcomes in patients with all types of cardiac arrhythmias. Dr. Hsu's research has resulted in publications in medical journals such as The New England Journal of Medicine, as well as several top cardiology journals, including Journal of the American College of Cardiology and Circulation.

Interview Questions
Q1.

Questions to come from Stat Reporters! 

Added By: joe_mccann
Q2.

What do you see as major opportunities and challenges with implementing the study, as they relate to patient recruitement, informed consent, data collection and sharing?

Added By: jvarsh
Q3.

Woult it be possible to reflect on the key elements of study design including  the choice of its primary measures, as well as the practicality of the utilization of claims data to meet the study overall objectives?

Added By: jvarsh

Are You Interested In These Questions?



Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.